Viewing StudyNCT04262089



Ignite Creation Date: 2024-05-06 @ 2:15 PM
Last Modification Date: 2024-10-26 @ 1:27 PM
Study NCT ID: NCT04262089
Status: COMPLETED
Last Update Posted: 2023-12-05
First Post: 2020-01-28

Brief Title: Neo-adjuvant Pembrolizumab in dMMR POLE-EDM Uterine Cancer Patients a Feasibility Study
Sponsor: University Medical Center Groningen
Organization: University Medical Center Groningen

Conditions & Keywords Data

Conditions:
Name
Uterine Cancer
Keywords:
Name View
Uterine cancer View
dMMR View
POLE-EDM View
neo-adjuvant View
pembrolizumab View